These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of Alzheimer's disease: rationale and strategies. Grundman M; Thal LJ Neurol Clin; 2000 Nov; 18(4):807-28. PubMed ID: 11072262 [TBL] [Abstract][Full Text] [Related]
8. New drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy. Dening T; Lawton C BMJ; 1998 Oct; 317(7163):945. PubMed ID: 9756823 [No Abstract] [Full Text] [Related]
9. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Vellas B; Carrillo MC; Sampaio C; Brashear HR; Siemers E; Hampel H; Schneider LS; Weiner M; Doody R; Khachaturian Z; Cedarbaum J; Grundman M; Broich K; Giacobini E; Dubois B; Sperling R; Wilcock GK; Fox N; Scheltens P; Touchon J; Hendrix S; Andrieu S; Aisen P; Alzheimers Dement; 2013 Jul; 9(4):438-44. PubMed ID: 23809364 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of donepezil in Alzheimer's disease: fact or artifact? van Gool WA Neurology; 1999 Jan; 52(1):218-9. PubMed ID: 9921890 [No Abstract] [Full Text] [Related]
12. New and different approaches needed for the design and execution of Alzheimer's clinical trials. Carrillo MC; Vellas B Alzheimers Dement; 2013 Jul; 9(4):436-7. PubMed ID: 23809363 [No Abstract] [Full Text] [Related]
13. Can we do better in developing new drugs for Alzheimer's disease? Gauthier S; Scheltens P Alzheimers Dement; 2009 Nov; 5(6):489-91. PubMed ID: 19896588 [TBL] [Abstract][Full Text] [Related]
14. The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease. Farlow MR Lancet Neurol; 2009 Jan; 8(1):22-3. PubMed ID: 19042160 [No Abstract] [Full Text] [Related]
15. Merck ends trial of potential Alzheimer's drug verubecestat. Hawkes N BMJ; 2017 Feb; 356():j845. PubMed ID: 28202490 [No Abstract] [Full Text] [Related]
16. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Ehret MJ; Chamberlin KW Clin Ther; 2015 Aug; 37(8):1604-16. PubMed ID: 26122885 [TBL] [Abstract][Full Text] [Related]
17. Assessing health economic outcome in Alzheimer's disease clinical trials. Jonsson L J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498 [TBL] [Abstract][Full Text] [Related]